DME Capital Management, LP: BIO position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of DME Capital Management, LP on BIO, newest first. How the timeline and the estimate are built.
DME Capital Management, LP held 103,990 BIO shares at 2026-09-30 per its 13F-HR filed 2026-11-16.
the latest 13F is the newest step
- period ended2026-09-3013F 103,990 sharesChange vs previous 13F not available
1.11% of the 13F portfolio, value $39,278,063.
13F-HR 0001172661-26-005372 filed by DME Capital Management, LP
Accepted , ingested